Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials
                              
 
                                  Event:
                                  
                                    ESC Congress 2019
                                  
 
                                  Topic:
                                  
                                    Diabetes and the Heart
                                  
 
                                  Session:
                                  
                                    Progress in secondary prevention - New treatments